IONS Stock Analysis: Buy, Sell, or Hold?
IONS - Ionis Pharmaceuticals, Inc. Common Stock
$82.67
-1.21 (-1.44%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026
17d
Get Alerted When IONS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called IONS this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: IONS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: IONS shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: IONS is currently trading at $82.67, which is considered extended relative to its 30-day fair value range of $78.57 to $82.12.
Technical Outlook: Technically, IONS is in a strong uptrend. The price is approaching resistance at $84.30. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IONS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, IONS is in a strong uptrend. The price is approaching resistance at $84.30. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: IONS has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Fair Price Range
$78.57 -
$82.12
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
57.9%
Protect Your Profits
Holding IONS? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($90.67)
Fair Price Analysis
30-Day Fair Range
$78.57 -
$82.12
Current vs Fair Value
EXTENDED
Support & Resistance Levels
Support Level
$74.20
Resistance Level
$84.30
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-36.64
Wall Street Target
$90.67
(+8.1%)
Revenue Growth (YoY)
17.1%
Earnings Growth (YoY)
-43.7%
Profit Margin
-26.5%
Last updated: January 31, 2026 5:50 AM ET
Data refreshes hourly during market hours. Next update: 6:50 AM
Data refreshes hourly during market hours. Next update: 6:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is IONS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Shannon L Devers
SELL
1263 shares
2025-10-16
Eric Swayze
SELL
53 shares
2025-10-16
B Lynne Parshall
SELL
5000 shares
2025-10-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
19 analysts |
$214 | 60 BUY |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$93 | 56 HOLD |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$273 | 59 HOLD |
|
MLTX
MoonLake Immunotherapeut… |
STRONG BUY
16 analysts |
$19 | 55 HOLD |
Advanced IONS Option Strategies
Professional options setups generated by AI based on today's IONS price and gamma walls.
